Organocatalytic direct aldol and nitroaldol reactions between azetidine-2,3-diones and ketones or nitromethane

Tetrahedron

Volumn 63, Issue 15, 2007, Pages 3102-3107

  Alcaide, Benito ^a   Almendros, Pedro ^b   Luna, Amparo ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INSTITUTO DE QUÍMICA ORGÁNICA GENERAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZETIDINE DERIVATIVE; KETONE DERIVATIVE; METHYLEPHEDRINE; NITROMETHANE; PROLINE;

ALDOL REACTION; ARTICLE; CHEMICAL REACTION; PRIORITY JOURNAL; STEREOCHEMISTRY;

EID: 33847624210     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2007.02.024     Document Type: Article

References (83)

1. For recent selected reviews, see:
2. In: Koćovský P., and Malkov A.V. (Eds). Tetrahedron 62 (2006) 243-502 issues 2 and 3: Organocatalysis in Organic Synthesis
3. List B. Chem. Commun. (2006) 819
4. In: Berkessel A., and Gröger H. (Eds). Asymmetric Organocatalysis: From Biomimetic Concepts to Applications in Asymmetric Synthesis (2005), Wiley-VCH, Weinheim
5. Dalko P.I., and Moisan D.L. Angew. Chem., Int. Ed. 43 (2004) 5138
6. Johnson J.S. Angew. Chem., Int. Ed. 43 (2004) 1326
7. In: List B., and Bolm C. (Eds). Adv. Synth. Catal. 346 (2004) 1007-1249 issues 9 and 10: Organic Catalysis Issue
8. In: Houk K.N., and List B. (Eds). Acc. Chem. Res. 37 (2004) 487-631 issue 8: Asymmetric Organocatalysis
9. Dalko P.I., and Moisan D.L. Angew. Chem., Int. Ed. 40 (2001) 3726
10. For general reviews on aldol reactions, see:
11. Schetter B., and Mahrwald R. Angew. Chem., Int. Ed. 45 (2006) 7506
12. In: Mahrwald R. (Ed). Modern Aldol Reactions (2004), Wiley-VCH, Weinheim
13. Palomo C., Oiarbide M., and García J.M. Chem. Soc. Rev. 33 (2004) 65
14. Palomo C., Oiarbide M., and García J.M. Chem.-Eur. J. 8 (2002) 37
15. Machajewski T.D., and Wong C.-H. Angew. Chem., Int. Ed. 39 (2000) 1352
16. For selected reviews on catalytic direct aldol reactions, see:
17. Notz W., Tanaka F., and Barbas III C.F. Acc. Chem. Res. 37 (2004) 580
18. List B. Acc. Chem. Res. 37 (2004) 548
19. Alcaide B., and Almendros P. Angew. Chem., Int. Ed. 42 (2003) 858
20. Jarvo E.R., and Miller S.J. Tetrahedron 58 (2002) 2481
21. List B. Tetrahedron 58 (2002) 5573
22. Alcaide B., and Almendros P. Eur. J. Org. Chem. (2002) 1595
23. For matching and mismatching effects in the proline-catalyzed aldol reaction of enantiopure aldehydes, see:
24. Alcaide B., Almendros P., and Luna A. J. Org. Chem. 71 (2006) 4818
25. Calderón F., Doyagüez E.G., and Fernández-Mayoralas A. J. Org. Chem. 71 (2006) 6258
26. Casas J., Engqvist M., Ibrahem I., Kaynak B., and Córdova A. Angew. Chem., Int. Ed. 44 (2005) 1343
27. Pan Q., Zou B., Wang Y., and Ma D. Org. Lett. 6 (2004) 1009
28. Chowdari N.S., Ramachary D.B., and Barbas III C.F. Org. Lett. 5 (2003) 1685
29. Izquierdo I., Plaza M.T., Robles R., Mota A.J., and Franco F. Tetrahedron: Asymmetry 12 (2001) 2749
30. The 3-substituted 3-hydroxy-β-lactam moiety represents an efficient carboxylate mimic, see:
31. Unkefer C.J., London R.E., Durbin R.D., Uchytil T.F., and Langston-Unkefer P.J. J. Biol. Chem. 262 (1987) 4993
32. Meek T.D., and Villafranca J.V. Biochemistry 19 (1980) 5513
33. Sinden S.L., and Durbin R.D. Nature 219 (1968) 379 The 3-substituted 3-hydroxy-β-lactam moiety is present in several pharmacologically active monobactams such as sulphazecin and related products, see:
34. Imada A., Kitano K., Kintana K., Muroi M., and Asai M. Nature 289 (1981) 590
35. The 3-substituted 3-hydroxy-β-lactam moiety is present in enzyme inhibitors such as tabtoxin and its analogues. See:
36. Dolle R.E., Hughes M.J., Li C.-S., and Kruse L.I. J. Chem. Soc., Chem. Commun. (1989) 1448
37. Greenlee W.J., Springer J.P., and Patchett A.A. J. Med. Chem. 32 (1989) 165
38. Baldwin J.E., Otsuka M., and Wallace P.M. Tetrahedron 42 (1986) 3097
39. Stewart W.W. Nature 229 (1971) 174 Some 3-substituted 3-hydroxy-β-lactams showed promising activity in acyl CoA-cholesterol acyltransferase inhibition assays, see:
40. Benfatti F., Cardillo G., Gentilucci L., Perciaccante R., Tolomelli A., and Catapano A. J. Org. Chem. 71 (2006) 9229
41. Isoserines are key components of a large number of therapeutically important compounds. As an example, (2R,3S)-3-amino-2-hydroxy-5-methylhexanoic acid (norstatine) and (3R,4S)-4-amino-3-hydroxy-5-methylheptanoic acid (statine) are residues for peptide inhibitors of enzymes, such as renin and HIV-1 protease, see:
42. Thaisrivongs S., Pals D.T., Kroll L.T., Turner S.R., and Han F.-S. J. Med. Chem. 30 (1987) 976
43. Huff J.R. J. Med. Chem. 34 (1991) 2305 Moreover, phenylisoserine analogues are used to synthesize new taxoids
44. Lucatelli C., Viton F., Gimbert Y., and Greene A.E. J. Org. Chem. 67 (2002) 9468
45. Ojima I., Wang T., and Delaloge F. Tetrahedron Lett. 39 (1998) 3663
46. Ojima I., Kuduk S.D., Pera P., Veith J.M., and Bernacki R.J. J. Med. Chem. 40 (1997) 267
47. Alcaide B., Almendros P., and Martínez del Campo T. Angew. Chem., Int. Ed. 45 (2006) 4501
48. Alcaide B., Almendros P., and Redondo M.C. Chem. Commun. (2006) 2616
49. Alcaide B., Almendros P., Aragoncillo C., Redondo M.C., and Torres M.R. Chem.-Eur. J. 12 (2006) 1539
50. Alcaide B., Almendros P., and Rodríguez-Acebes R. J. Org. Chem. 71 (2006) 2346
51. Alcaide B., Almendros P., and Alonso J.M. Chem.-Eur. J. 12 (2006) 2874
52. Alcaide B., Almendros P., Aragoncillo C., and Rodríguez-Acebes R. J. Org. Chem. 66 (2001) 5208 For a review on the chemistry of azetidine-2,3-diones, see:
53. Alcaide B., and Almendros P. Org. Prep. Proced. Int. 33 (2001) 315
54. For reviews, see:
55. Gryko D., Chalko J., and Jurczak J. Chirality 15 (2003) 514
56. Reetz M.T. Chem. Rev. 99 (1999) 1121
57. Reetz M.T. Angew. Chem., Int. Ed. Engl. 30 (1991) 1531
58. Jurczak J., and Golebiowski A. Chem. Rev. 89 (1989) 149
59. For the proline-catalyzed direct aldol reaction of aldehydes with α-keto esters as aldol acceptors, see:
60. Bøgevig A., Kumaragurubaran N., and Jørgensen K.A. Chem. Commun. (2002) 620 For the proline-catalyzed asymmetric aldol reaction between cyclohexanone and phenylglyoxylate, see:
61. Tokuda O., Kano T., Gao W.-G., Ikemoto T., and Maruoka K. Org. Lett. 7 (2005) 5107 For the dipeptide-catalyzed asymmetric aldol condensation of acetone with N-alkylated isatins, see:
62. Luppi G., Cozzi P.G., Monari M., Kaptein B., Broxterman Q.B., and Tomasini C. J. Org. Chem. 70 (2005) 7418 For the organo-catalyzed asymmetric direct aldol reaction of acetone with α-keto acids, see:
63. Tang Z., Cun L.-F., Cui X., Mi A.-Q., Jiang Y.-Z., and Gong L.-Z. Org. Lett. 8 (2006) 1263
64. A typical reaction of azetidine-2,3-diones 1 was catalyzed (10 mol %) by N-benzylglycine and was conducted in acetone for a period of 2 days (conversion up to 5%).
65. A typical reaction of azetidine-2,3-diones 1 was catalyzed (10 mol %) by glycine and was conducted in acetone for a period of 3 days (yield up to 45%).
66. A typical reaction of azetidine-2,3-diones 1 was catalyzed (10-15 mol %) by triethylamine or Hünig's base and was conducted in acetone at room temperature.
67. A typical reaction of azetidine-2,3-diones 1 was catalyzed (10 mol %) by the system pyrrolidine/acetic acid (1:1) and was conducted in acetone for a period of 24 h. In addition to the aldol product (yield up to 31%), some epimerization on the starting ketone was detected.
68. For a review, see:
69. Palomo C., Oiarbide M., and Mielgo A. Angew. Chem., Int. Ed. 43 (2004) 5442 For selected recent references, see:
70. Marcelli T., van der Haas R.N.S., van Maarseveen J.H., and Hiemstra H. Angew. Chem., Int. Ed. 45 (2006) 929
71. Li H., Wang B., and Deng L. J. Am. Chem. Soc. 128 (2006) 732
72. Saá J.M., Tur F., González J., and Vega M. Tetrahedron: Asymmetry 17 (2006) 99
73. Sohtome Y., Hashimoto Y., and Nagasawa K. Eur. J. Org. Chem. (2006) 2894
74. Gan C., Lai G., Zhang Z., Wang Z., and Zhou M.-M. Tetrahedron: Asymmetry 17 (2006) 725
75. Maheswaran H., Prasanth K.L., Krishna G.G., Ravikumar K., Sridhar B., and Kantam M.L. Chem. Commun. (2006) 4066
76. Palomo C., Oiarbide M., and Laso A. Angew. Chem., Int. Ed. 44 (2005) 3881
77. For selected reviews, see:
78. Ono N. The Nitro Group in Organic Synthesis (2001), Wiley-VCH, New York, NY
79. Luzzio F.A. Tetrahedron 57 (2001) 915
80. Ballini R., Bosica G., Fiorini D., and Palmieri A. Tetrahedron 61 (2005) 8971
81. Match implies that the catalyst reinforces the inherent diastereoselectivity of the substrate, and mismatch implies that the catalyst contradicts the inherent diastereoselectivity. With matched catalyst/substrate pairs, the selectivity is universally excellent. Furthermore, in every mismatched case, the catalyst is able to override and control the diastereoselectivity of the addition.
82. The use of triethylamine (35 mol %) as promoter instead of N-methylephedrine in the nitroaldol reaction of azetidine-2,3-diones 1 was equally effective, being obtained the corresponding Henry adducts 5 in similar yields.
83. For a review on the principles of double- and reagent-controlled stereoselection in the context of the aldol reaction, see:. Masamune S., Choy W., Petersen J.S., and Sita L.R. Angew. Chem., Int. Ed. Engl. 24 (1985) 1